Document 0739 DOCN M9550739 TI An animal model for antilentiviral therapy: effect of zidovudine on viral load during acute infection after exposure of macaques to simian immunodeficiency virus. DT 9505 AU Le Grand R; Clayette P; Noack O; Vaslin B; Theodoro F; Michel G; Roques P; Dormont D; Laboratoire de Neuropathologie Experimentale et Neurovirologie,; Centre de Recherches du Service de Sante des Armees,; Fontenay-aux-Roses, France. SO AIDS Res Hum Retroviruses. 1994 Oct;10(10):1279-87. Unique Identifier : AIDSLINE MED/95151365 AB We analyzed the kinetics of the virological and immunological events that occurred in four AZT-treated cynomolgus macaques during the acute infection that followed their exposure to the simian immunodeficiency virus (SIVmac251) grown on monkey PBMCs in a cell-free stock solution. These events included changes in the CD4+ and CD8+ T lymphocyte subsets, p27 antigenemia, infectious serum virus, and cell-associated virus loads. The kinetics of these changes proved strikingly similar to those reported in human HIV-1 infection. Four other SIV-exposed macaques were treated with placebo instead of AZT. We demonstrated that AZT does not prevent SIV infection, even when administered before SIV inoculation. However, the peaks of p27 antigenemia and of serum and cellular viremia were significantly smaller and occurred significantly later in the monkeys given AZT than in those given placebo. DE Acquired Immunodeficiency Syndrome/DRUG THERAPY/IMMUNOLOGY/ VIROLOGY Animal Antibodies, Viral/BLOOD Comparative Study CD4-Positive T-Lymphocytes/IMMUNOLOGY CD8-Positive T-Lymphocytes/IMMUNOLOGY Human HIV-1/DRUG EFFECTS Macaca fascicularis Simian Acquired Immunodeficiency Syndrome/*DRUG THERAPY/ IMMUNOLOGY/VIROLOGY Support, Non-U.S. Gov't SIV/DRUG EFFECTS/ISOLATION & PURIF/*PHYSIOLOGY T-Lymphocyte Subsets/IMMUNOLOGY Virion/ISOLATION & PURIF Zidovudine/*THERAPEUTIC USE JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).